Mono Pharmacare Ltd | Industry : Pharmaceuticals | |
---|---|---|
|
|
|
|
|
|
|
|
|
Mar '2024 | Mar '2023 | ||||
---|---|---|---|---|---|
SOURCES OF FUNDS : | |||||
Equity Share Capital | 17.67 | 12.37 | |||
Reserves | 10.44 | 1.03 | |||
Equity Share Warrants | 0.00 | 0.00 | |||
Equity Application Money | 0.00 | 0.00 | |||
Total Shareholders Funds | 28.11 | 13.40 | |||
Secured Loans | 9.81 | 10.00 | |||
Unsecured Loans | 3.46 | 2.51 | |||
Total Debt | 13.27 | 12.51 | |||
Other Liabilities | 0.04 | 0.00 | |||
Total Liabilities | 41.42 | 25.91 | |||
APPLICATION OF FUNDS : | |||||
Gross Block | 0.24 | 0.21 | |||
Less: Accumulated Depreciation | 0.10 | 0.02 | |||
Less:Impairment of Assets | 0.00 | 0.00 | |||
Net Block | 0.14 | 0.19 | |||
Lease Adjustments | 0.00 | 0.00 | |||
Capital Work in Progress | 0.00 | 0.00 | |||
Investments | 3.59 | 1.97 | |||
Current Assets, Loans & Advances | |||||
Inventories | 20.99 | 15.18 | |||
Sundry Debtors | 17.44 | 8.08 | |||
Cash and Bank Balance | 0.25 | 0.23 | |||
Loans and Advances | 2.96 | 3.35 | |||
Total Current Assets | 41.64 | 26.84 | |||
Less : Current Liabilities and Provisions | |||||
Current Liabilities | 3.71 | 2.71 | |||
Provisions | 0.27 | 0.45 | |||
Total CL & Provisions | 3.98 | 3.16 | |||
Net Current Assets | 37.66 | 23.68 | |||
Miscellaneous Expenses not written off | 0.00 | 0.00 | |||
Deferred Tax Assets | 0.01 | 0.05 | |||
Deferred Tax Liability | 0.00 | 0.00 | |||
Net Deferred Tax | 0.01 | 0.05 | |||
Other Assets | 0.01 | 0.01 | |||
Total Assets | 41.41 | 25.90 | |||
Contingent Liabilities | 0.00 | 0.00 |